IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition

被引:210
作者
Morali, OG
Delmas, V
Moore, R
Jeanney, C
Thiery, JP
Larue, L
机构
[1] Inst Curie, UMR 146 CNRS, F-91405 Orsay, France
[2] Inst Curie, UMR 144 CNRS, F-75248 Paris 05, France
关键词
cadherin; catenin; insulin-like growth factor; epithelium to mesenchyme transition;
D O I
10.1038/sj.onc.1204660
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The epithelium to mesenchyme transition is thought to play a fundamental role during embryonic development and tumor progression. Loss of cell-cell adhesion and modification of both cell morphology and gene expression are the main events associated with this transition. There is a large amount of evidence suggesting that growth factors can initiate these events. Yet, the connection from growth factor induction to changes in cell adhesion and morphology is largely unknown. To elucidate this connection, we have investigated the action of IGF-II on E-eadherin/beta -catenin complex-mediated cell-cell adhesion and on beta -catenin/TCF-3 mediated gene expression. We can show that (1) IGF-II induces a rapid epithelium to mesenchymal transition; (2) IGF1R, the receptor for IGF-II, belongs to the same membrane complex as E-cadherin and beta -catenin; (3) IGF-II induces a redistribution of beta -catenin from the plasma membrane to the nucleus and an intracellular sequestration and degradation of E-cadherin; (4) IGF-II induces the transcription of beta -catenin/TCF-3 target genes. Based on the given case of IGF-II and E-eadherin/beta -catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling with cell-cell adhesion during EMT.
引用
收藏
页码:4942 / 4950
页数:9
相关论文
共 51 条
  • [1] Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.3.CO
  • [2] 2-D
  • [3] Mechanism of activation of protein kinase B by insulin and IGF-1
    Alessi, DR
    Andjelkovic, M
    Caudwell, B
    Cron, P
    Morrice, N
    Cohen, P
    Hemmings, BA
    [J]. EMBO JOURNAL, 1996, 15 (23) : 6541 - 6551
  • [4] André F, 1999, INT J CANCER, V83, P497, DOI 10.1002/(SICI)1097-0215(19991112)83:4<497::AID-IJC11>3.3.CO
  • [5] 2-4
  • [6] Nuclear endpoint of Wnt signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1
    Aoki, M
    Hecht, A
    Kruse, U
    Kemler, R
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 139 - 144
  • [7] BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  • [8] The IGF-I receptor in cancer research
    Baserga, R
    [J]. EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) : 1 - 6
  • [9] Baserga R, 1999, J CELL BIOCHEM, P68
  • [10] Pontin52, an interacticon partner of β-catenin, binds to the TATA box binding protein
    Bauer, A
    Huber, O
    Kemler, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14787 - 14792